These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32913568)

  • 21. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
    Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
    Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
    Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
    Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
    Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
    Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism, prevention, and treatment for medication-related osteonecrosis of the jaws.
    Pan J; Liu JY
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Jun; 39(3):245-254. PubMed ID: 34041871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis.
    Dos Santos Ferreira L; Abreu LG; Calderipe CB; Martins MD; Schuch LF; Vasconcelos ACU
    Osteoporos Int; 2021 Dec; 32(12):2449-2459. PubMed ID: 34331067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral risk factors associated with medication-related osteonecrosis of the jaw in patients with cancer.
    Ueda N; Aoki K; Shimotsuji H; Nakashima C; Kawakami M; Imai Y; Kirita T
    J Bone Miner Metab; 2021 Jul; 39(4):623-630. PubMed ID: 33420576
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
    Kawahara M; Kuroshima S; Sawase T
    Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The progress of medication-related osteonecrosis of the jaw with conservative initial treatment: A 12-year retrospective study of 129 patients.
    Kaibuchi N; Hoshi K; Yamazaki A; Miyamoto-Sangu N; Akagi Y; Okamoto T
    Bone Rep; 2021 Jun; 14():101072. PubMed ID: 33997149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Case of Medication-Related Osteonecrosis of the Jaw Addressed from a Pathogenic Point of View. Innovative Therapeutic Strategies: Focus on the Most Recent Discoveries on Oral Mesenchymal Stem Cell-Derived Exosomes.
    Giudice A; Antonelli A; Chiarella E; Baudi F; Barni T; Di Vito A
    Pharmaceuticals (Basel); 2020 Nov; 13(12):. PubMed ID: 33255626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic comorbidities are associated with medication-related osteonecrosis of the jaws: Case-control study.
    McGowan K; Acton C; Ivanovski S; Johnson NW; Ware RS
    Oral Dis; 2019 May; 25(4):1107-1115. PubMed ID: 30674072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medication-related osteonecrosis and osteoradionecrosis of the jaws: Update and current management.
    Kün-Darbois JD; Fauvel F
    Morphologie; 2021 Jun; 105(349):170-187. PubMed ID: 33281055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).
    Nica DF; Riviș M; Roi CI; Todea CD; Duma VF; Sinescu C
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562600
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis.
    Hayashida S; Soutome S; Yanamoto S; Fujita S; Hasegawa T; Komori T; Kojima Y; Miyamoto H; Shibuya Y; Ueda N; Kirita T; Nakahara H; Shinohara M; Umeda M
    J Bone Miner Res; 2017 Oct; 32(10):2022-2029. PubMed ID: 28585700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dentists' knowledge about medication-related osteonecrosis of the jaw and its management.
    Al-Eid R; Alduwayan T; Bin Khuthaylah M; Al Shemali M
    Heliyon; 2020 Jul; 6(7):e04321. PubMed ID: 32760820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.
    Taş Ozyurtseven B; Serin I; Nursal AF; Pehlivan S; Pehlivan M
    BMC Oral Health; 2021 May; 21(1):272. PubMed ID: 34006261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
    Kanwar N; Bakr MM; Meer M; Siddiqi A
    Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medication--related osteonecrosis of the jaws. The first reported cases in the Baltic States and a literature review.
    Zaleckas L; Stacevičius M; Proškutė D; Povilaitytė J
    Stomatologija; 2015; 17(3):89-96. PubMed ID: 26879401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical Management of Medication-Related Osteonecrosis of the Jaw Patients Related to Dental Implants.
    Nisi M; Izzetti R; Gennai S; Bellini P; Graziani F; Gabriele M
    J Craniofac Surg; 2020 Jun; 31(4):1037-1041. PubMed ID: 32102027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study.
    McGowan K; Ware RS; Acton C; Ivanovski S; Johnson NW
    Clin Oral Investig; 2019 Nov; 23(11):3967-3975. PubMed ID: 30747305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Several issues regarding the diagnostic imaging of medication-related osteonecrosis of the jaw.
    Kim JE; Yoo S; Choi SC
    Imaging Sci Dent; 2020 Dec; 50(4):273-279. PubMed ID: 33409135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.